| 产品描述: | CCI-007 is a small molecule with cytotoxic activity against infant leukemia with MLL rearrangements, with IC50 values of 2.5-6.2 μM in sensitive cells |
| 体外研究: |
CCI-007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia.
Following CCI-007 treatment for 24h, significant mitochondrial depolarization was observed in PER-485 cells as evidenced by a shift in JC-1 signal. CCI-007 alters the characteristic MLL-r gene expression signature in sensitive cells with downregulation of the expression of HOXA9, MEIS1, CMYC and BCL2.
Resistance to CCI-007 can occur by upregulation of MLL target gene expression. |
| 参考文献: |
1. Klaartje Somers, et al. CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements. Oncotarget. 2016 Jul 19;7(29):46067-46087.
2. Klaartje Somers, et al. A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction. Oncogene. 2019 May;38(20):3824-3842. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.973 ml |
14.865 ml |
29.73 ml |
| 5 mM |
0.595 ml |
2.973 ml |
5.946 ml |
| 10 mM |
0.297 ml |
1.487 ml |
2.973 ml |
| 50 mM |
0.059 ml |
0.297 ml |
0.595 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |